Related Experiment Video
Updated: Dec 27, 2025
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Update on Pediatric Optic Neuritis
Ryan A Gise1,2, Gena Heidary3,4
1Department of Ophthalmology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA, 02115, USA.
Insights
Advances in pediatric demyelinating optic neuritis reveal distinct disease phenotypes. Identifying specific causes, like myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease, is crucial for effective treatment and prognosis.
Area of Science:
- Ophthalmology
- Neurology
- Pediatrics
Background:
- Pediatric demyelinating optic neuritis phenotypes have been clarified over the last decade.
- Optic neuritis in children can be isolated or part of broader neurological conditions.
- Distinguishing between causes like multiple sclerosis, neuromyelitis optica, and MOG IgG is essential.
Purpose of the Study:
- To update on advancements in understanding pediatric demyelinating optic neuritis.
- To highlight the expanded disease phenotypes in pediatric demyelinating optic neuritis.
- To emphasize the importance of accurate diagnosis for treatment and prognosis.
Main Methods:
- Review of recent literature on pediatric demyelinating optic neuritis.
- Analysis of clinical presentations and diagnostic criteria.
- Evaluation of treatment strategies and prognostic indicators.
Main Results:
- Defined distinct disease phenotypes for pediatric demyelinating syndromes.
- Identified myelin oligodendrocyte glycoprotein (MOG IgG) as a unique cause with specific characteristics.
- Recognized variability in treatment effectiveness across different causes.
Conclusions:
- Accurate differentiation of pediatric demyelinating optic neuritis subtypes is critical.
- Timely and precise diagnosis guides appropriate treatment to prevent disability.
- Understanding specific etiologies improves visual outcome predictions and long-term prognosis.
Purpose Of Review:
The purpose of this review is to provide an update on advances in the understanding of pediatric demyelinating optic neuritis.
Recent Findings:
In the past decade, the disease phenotypes for demyelinating syndromes in children have been more clearly defined. Pediatric optic neuritis may present as a clinically isolated syndrome or in the setting of underlying neurologic disease. In addition to optic neuritis associated with multiple sclerosis or neuromyelitis optica, recent work has identified antibodies to the myelin oligodendrocyte glycoprotein (MOG IgG) as a unique demyelinating cause with distinct features regarding treatment and prognosis. The disease phenotypes for demyelinating pediatric optic neuritis have expanded. Treatment strategies vary and are not universally effective for each cause of demyelinating disease. Accurately distinguishing among these unique clinical syndromes is therefore critical for initiation of appropriate treatment to prevent disability, to maximize visual outcomes, and to provide insight into long-term prognosis.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
01:28Angle Closure Glaucoma: Treatment